This week’s episode of “The Top Line” is the second part of a three-part series exploring the latest advancements in cell and gene therapy manufacturing. In this episode, Fierce Pharma’s Fraiser ...

AT&T made the leap first, revealing that it plans to offer 8-GB and 16-GB iPhone 3G smartphones at a special "no-commit" price. That translates to $599 and $699, respectively, to avoid being locked ...

Pluri (PLUR), an established global leader in the development and manufacturing of cell-based therapeutics, launches new revenue-generating Contract Development and Manufacturing Organization (CDMO) ...

The repair and replacement of damaged tissues is an area of enormous potential for cellular therapies. In this context, molecular tailoring and bioprocessing are key components in cell therapeutics ...